8 November 2024 false No description of principal activity Taxfiler 2024.6 16067653business:PrivateLimitedCompanyLtd2024-11-082025-11-30 160676532024-11-07 160676532024-11-082025-11-30 16067653business:AuditExemptWithAccountantsReport2024-11-082025-11-30 16067653business:FilletedAccounts2024-11-082025-11-30 160676532025-11-30 16067653business:Director12024-11-082025-11-30 16067653business:Director22024-11-082025-11-30 16067653business:RegisteredOffice2024-11-082025-11-30 16067653core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 16067653core:PreviouslyStatedAmount2025-11-30 16067653business:SmallEntities2024-11-082025-11-30 16067653countries:EnglandWales2024-11-082025-11-30 iso4217:GBP xbrli:pure
Company Registration No. 16067653 (England and Wales)
Midas Biotech Ltd Unaudited accounts for the period from 8 November 2024 to 30 November 2025
Midas Biotech Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Midas Biotech Ltd Company Information for the period from 8 November 2024 to 30 November 2025
Directors
Diego Dolgetta Garcia Yusuf Islam
Company Number
16067653 (England and Wales)
Registered Office
10 Scarborough Street London E1 8DR England
Accountants
Elmers Green Accountancy Services Ltd 520 Birchwood Boulevard Birchwood, Warrington England WA3 7QX
- 3 -
Midas Biotech Ltd Statement of financial position as at 30 November 2025
2025 
Notes
£ 
Called up share capital not paid
200 
Net current assets
- 
Net assets
200 
Capital and reserves
Called up share capital
200 
Shareholders' funds
200 
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 5 August 2026 and were signed on its behalf by
Yusuf Islam Director Company Registration No. 16067653
- 4 -
Midas Biotech Ltd Notes to the Accounts for the period from 8 November 2024 to 30 November 2025
1
Statutory information
Midas Biotech Ltd is a private company, limited by shares, registered in England and Wales, registration number 16067653. The registered office is 10 Scarborough Street, London, E1 8DR, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the period the average number of employees was 2.
- 5 -